Mark Genovese
Academic Appointments
- Professor - Med Center Line, Medicine - Immunology & Rheumatology
Contact Information
-
Clinical Offices
Immunology & Rheumatology Clinic 300 Pasteur Dr A175 MC 5309 Stanford, CA 94305 Tel Work (650) 723-6961 Fax (650) 725-8418
Professional Snapshot
Clinical Focus
- Rheumatology
- Immunology/Rheumatology
Professional Education
| Fellowship: | Stanford University Medical Center, CA (1998) |
| Residency: | Stanford University Medical Center, CA (1996) |
| Residency: | Stanford University Medical Center, CA (1995) |
| Internship: | Stanford University Medical Center, CA (1993) |
| Medical Education: | Johns Hopkins University, MD (1992) |
Industry Relationships
Stanford is committed to ethical and transparent interactions with our industry partners. It is our policy to disclose payments of $5,000 or more, equity valued at $5,000 or more in a publicly traded company, or any equity in a privately held company, to physicians and scientists employed by Stanford University from companies or other commercial entities with which they interact as part of their professional activities. View Full Information
| Consulting: | Abbott, Ardea, Biogen Idec, Horizon, Kalobios, Rigel, Synarc |
Scientific Focus
Research Interests
Clinical trials and interventions in the rheumatic diseases including Rheumatoid Arthritis,Systemic Lupus Erythematosus, Systemic Sclerosis, Osteoarthritis.
Clinical Trials
Publications
- Efficacy of a p38 mitogen activated protein kinase inhibitor in mitigating an established inflammatory reaction to polyethylene particles in vivo. J Biomed Mater Res A. 2009; (1): 117-23
- First report of idiopathic granulomatous mastitis treated with methotrexate monotherapy. J Rheumatol. 2009; (7): 1559-60
- Inhibition of p38: has the fat lady sung? Arthritis Rheum. 2009; (2): 317-20
- Safety of biological therapies following rituximab treatment in rheumatoid arthritis patients. Ann Rheum Dis. 2009; (12): 1894-7
- Less radiographic progression with adalimumab plus methotrexate versus methotrexate monotherapy across the spectrum of clinical response in early rheumatoid arthritis. J Rheumatol. 2009; (7): 1429-41
Help